3.0
27 May 2026
Former employee, more than 1 year
Minneapolis, MN
Recommend
CEO approval
Business outlook
Pros
Strong exposure to the decentralized clinical trial ecosystem and the operational realities across sponsors, CROs, and research sites. Opportunity to work closely with founders and leadership while learning quickly in a fast-moving healthcare SaaS environment.
Cons
Company was still refining product positioning, ICP focus, and commercialization strategy while scaling. At times this created unclear expectations, broad targeting, and challenges building a repeatable sales motion.